Correlation Between DiaMedica Therapeutics and Lantern Pharma
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Lantern Pharma, you can compare the effects of market volatilities on DiaMedica Therapeutics and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Lantern Pharma.
Diversification Opportunities for DiaMedica Therapeutics and Lantern Pharma
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and Lantern is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Lantern Pharma go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Lantern Pharma
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.0 times more return on investment than Lantern Pharma. However, DiaMedica Therapeutics is 1.0 times less risky than Lantern Pharma. It trades about 0.14 of its potential returns per unit of risk. Lantern Pharma is currently generating about -0.09 per unit of risk. If you would invest 288.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 278.00 from holding DiaMedica Therapeutics or generate 96.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Lantern Pharma
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Lantern Pharma |
DiaMedica Therapeutics and Lantern Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Lantern Pharma
The main advantage of trading using opposite DiaMedica Therapeutics and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Generation Bio Co | Lantern Pharma vs. Lyra Therapeutics | Lantern Pharma vs. Immunome |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |